KINASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

SUBSTITUTED PYRROLOPYRIDINE JAK INHIBITORS AND METHODS OF MAKING AND USING THE SAME

Benzisoxazole Sulfonamide Derivatives

GENE THERAPY FOR LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 2C

COMPOSITIONS AND METHODS RELATED TO ANTI-CD19 ANTIBODY DRUG CONJUGATES

BIPARATOPIC FR-ALPHA ANTIBODIES AND IMMUNOCONJUGATES

METHODS OF PRODUCING EXPANDED NATURAL KILLER CELLS FROM CRYOPRESERVED APHERESIS SAMPLES AND USES THEREOF

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DILATED CARDIOMYOPATHY

P21 Expressing Monocytes for Cancer Cell Therapy

NASAL DELIVERY OF APIGENIN AND LINEAR PEPTIDE INHIBITORS OF MITOCHONDRIAL FISSION

METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BARTH SYNDROME

NATURAL KILLER CELLS

PLATELET-RICH PLASMA COMPOSITIONS, PREPARATION, AND USES THEREOF

METHOD AND SYSTEM FOR TREATMENT OF BONE OR JOINT

ANTI-VTCN1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Charged Ion Channel Blockers And Methods For Use

METHODS AND COMPOSITIONS FOR RADIOPROTECTION AND MITIGATION OF RADIATION-INDUCED INJURY USING KINASE INHIBITORS

Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof

METHODS FOR THE TREATMENT OF LYMPHOPROLIFERATIVE DISORDERS

METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT USING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE

METHODS AND COMPOSITIONS FOR TREATING SEPSIS

METHODS AND AGENTS THAT STIMULATE MITOCHONDRIAL TURNOVER FOR TREATING DISEASE

GAMMA-SECRETASE INHIBITORS FOR USE IN THE TREATMENT OF INHERITED EPIDERMOLYSIS BULLOSA

METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECT WITH ATRIAL FIBRILLATION AND/OR ATRIAL FLUTTER

METHODS OF ADMINISTRATION FOR HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER

METHOD FOR TREATING DAMAGE INDUCED BY SLEEP DEPRIVATION

NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A AGONISTS AND METHODS OF USE FOR TREATMENT OF INFECTIOUS DISEASES

OVARIAN CANCER VACCINES

INDOLIUM-BASED STABILIZERS OF HYDROPHOBIC DRUGS

TALC-FREE ACTIVE INGREDIENT COATING

SEMI-SOLID ORAL DOSAGE FORM WITH ENCAPSULATED ACTIVE INGREDIENT

DRUG DELIVERY FOR INTERVERTEBRAL DISC PAIN MANAGEMENT

MARKERS SELECTIVELY DEREGULATED IN TUMOR-INFILTRATING REGULATORY T CELLS

METHOD FOR SCREENING AND PREPARING IMMUNOMODULATOR

METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE

BISPECIFIC T CELL ENGAGERS

COMBINATION THERAPIES

METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST

GLYCOENGINEERED POLYPEPTIDES TARGETING IMMUNOGLOBULIN A AND COMPLEXES COMPRISING THE SAME

CHIMERIC NK RECEPTOR AND METHODS FOR TREATING CANCER

INCRETIN ANALOG AND USE THEREOF

TLR7 AGONISTS

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

Bicyclic pyrimidinones as inhibitors of NOX4

TRIAZINE COMPOUNDS AND USES THEREOF

HYDROQUINAZOLINE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER

HETEROCYCLIC GLP-1 AGONISTS

CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS

HETEROCYCLIC INHIBITORS OF MCT4

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

RADIOCONJUGATES TARGETING CD33 IN THE TREATMENT OF BREAST CANCER

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR AND ASSOCIATED METHODS OF USE

COMBINATION OF RADIATION/CHEMOTHERAPY, PD-1 INHIBITOR AND FATTY ACID SYNTHASE INHIBITOR

STEROLS AS NOVEL IMMUNOMODULATORY AGENTS AND THEIR USE AS VACCINE ADJUVANTS

INTERLEUKIN-2 MUTANT AND FUSION PROTEIN THEREOF

METHODS AND COMPOSITIONS FOR TREATING CANCER

PHARMACEUTICAL COMPOSITIONS

PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS

COMBINATION OF NON-VIABLE CELLS OF STREPTOCOCCUS PYOGENES AND IMMUNE CHECKPOINT INHIBITOR FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER AND NON-MUSCLE INVASIVE BLADDER CANCER

ACELLULAR ALLOGENIC EXOSOME PREPARATIONS AND METHODS OF USE

DEVICE FOR PROCESSING TISSUE

METHODS AND COMPOSITIONS FOR TREATMENT OF AMYLOID-RELATED DISORDERS

COMPOSITION OF NOVEL CARBOHYDRATE DRUG FOR TREATMENT OF HUMAN DISEASES

PHARMACEUTICAL COMPOSITIONS COMPRISING SUBSTITUTED NUCLEOTIDES AND NUCLEOSIDES FOR TREATING VIRAL INFECTIONS

COMPOSITIONS AND METHODS FOR TREATING CARDIOMYOPATHIES

COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES

TREATMENT REGIMENS FOR GEDATOLISIB IN HORMONALLY-DRIVEN DISORDERS

NOVEL USES

ALPHA POLYGLUTAMATED AMINOPTERIN AND USES THEREOF

Compositions and Methods for the Restoration of Ciliary Function

COMPOUNDS FOR TREATING CANCER

CYANO-SUBSTITUTED CYCLIC HYDRAZINE DERIVATIVE AND APPLICATION THEREOF

COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES

USES OF SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) COMPOUNDS FOR QUALITY WEIGHT LOSS

Hepatoprotective Compositions And Methods

USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER

DOSAGE REGIME WITH ESKETAMINE FOR TREATING NEUROPSYCHIATRIC OR NEUROLOGICAL CONDITIONS

DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR

INHALABLE COMPOSITIONS OF CDK9 INHIBITORS

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

SEMIFLUORINATED ALKANE TETRACYCLINE COMBINATION COMPOSITIONS FOR TREATMENT OF MALAR EDEMA

METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS

ANTI-TREM2 ANTIBODIES AND METHODS OF USE

Anti-HIV Antibody 10-1074 Variants

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO CYTOKINES

METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND CD122/CD132 AGONISTS FOR THE TREATMENT OF CANCER

TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF

CHIRAL SYNTHESIS OF FUSED BICYCLIC RAF INHIBITORS

PROTEIN ANTIGENS AND USES THEREOF

METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE

TREATMENT OR PREVENTION OF GASTROINTESTINAL IMMUNOTHERAPY SIDE EFFECTS

TREATMENT OF RETINAL GANGLION CELL LOSS

DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION

METHODS AND COMPOSITIONS FOR PRESERVING THE RETINAL OUTER NUCLEAR LAYER (ONL), PHOTORECEPTORS, AND RETINAL THICKNESS

METHODS OF ADMINISTERING NATURAL KILLER CELLS COMPRISING AN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2) CHIMERIC ANTIGEN RECEPTOR (CAR)

METHOD OF TREATING ALZHEIMER'S DISEASE WITH EXPANDED NATURAL KILLER CELLS

COMBINED TREATMENT COMPOSITION FOR TUMOR TREATMENT AND COMBINED TREATMENT METHOD

METHODS FOR DECREASING OR INHIBITING HUMAN L1 RETROTRANSPOSON RNA AND COMPOSITIONS FOR USE THEREIN

METHODS FOR TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC)

METHODS FOR TREATING CANCER USING INHALED ANGIOGENESIS INHIBITOR

SMALL-MOLECULE ACTIVATORS OF MYCOBACTERIUM TUBERCULOSIS ADENYLYL CYCLASE

Tamper-resistant drug dosage forms and methods of making and use thereof

PHARMACEUTICAL FORMULATION WITH IMPROVED SOLUBILITY AND BIOAVAILABILITY

ORGANOGELS FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF

TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER

CHOLESTEROL-MODIFIED HYALURONIC ACIDS

ENHANCEMENT OF PHAGOCYTOSIS

BISPECIFIC IMMUNOTOXINS TARGETING HUMAN CD25+CCR4+ TUMORS AND REGULATORY T-CELLS

PROTEASE-CLEAVABLE MOIETIES AND METHODS OF USE THEREOF

CD73 INHIBITORS

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS

HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

2(1H)-PYRIDINIMINE DERATIVE

PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES

SUBSTITUTED BENZIMIDAZOLES FOR TREATING VIRAL DISEASES

DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR

NOVEL COMPOSITIONS FOR DISRUPTING BIOFILMS

PORCINE COLLAGEN COMPOSITIONS AND METHODS OF USE THEREOF

Vasopressin Formulations for Use in Treatment Of Hypotension

COMPOSITIONS AND USES OF LOCALLY-APPLIED ANTIMICROBIAL SYNTHETIC CATIONIC POLYPEPTIDE(S) WITH ENHANCED PERFORMANCE AND SAFETY

BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION

VACCINE ADJUVANTS AND FORMULATIONS

MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA

MUCUS MEMBRANE FORMULATIONS AND USES THEREOF

COMBINATION THERAPY OF CDK7 INHIBITORS WITH OTHER ANTI-CANCER THERAPIES

METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA

ORGANIC COMPOUNDS

METHOD OF TREATING HYPERTENSION WITH THE ALDOSTERONE SYNTHASE INHIBITOR BAXDROSTAT

Combination Therapy

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

PREVENTION OF ROSACEA INFLAMMATION

APPLICATION OF TOOSENDANIN IN INHIBITING AURKA KINASE

Compositions And Methods for Treating Acute Respiratory Distress Syndrome (ARDS) And Inflammatory Disorders Caused by Corona Viruses and Other Respiratory Pathogens or Agents That Mediate Pulmonary Injury, Inflammation or Acute Respiratory Distress, And Related Compositions and Methods for Treating and Preventing Human SARS Coronavirus Infection, COVID-19 Disease and Related Symptoms

PRECLINICAL DEVELOPMENT OF A ROMIDEPSIN NANOPARTICLE DEMONSTRATES SUPERIOR TOLERABILITY AND EFFICACY IN MODELS OF HUMAN T-CELL LYMPHOMA AND LARGE GRANULAR LYMPHOCYTE LEUKEMIA

NEBULIZATION FORMULATIONS FOR DELIVERY TO LOWER RESPIRATORY TRACT

GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE

METHODS OF TREATING CANCER

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

COMBINATION TREATMENT FOR CANCER

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

MULTISPECIFIC ANTIBODY AND USE THEREOF

ANTI-ADRENOMEDULIN NON-NEUTRALIZING ANTIBODY, METHOD FOR PREPARING SAME, AND USE THEREOF

ACYLATED GLUCAGON ANALOGUES

BONE FORMATION PROMOTING POLYPEPTIDE AND APPLICATION THEREOF

BRINP2-DERIVED PEPTIDE COMPOSITIONS FOR TREATING OBESITY AND WEIGHT MANAGEMENT

1`-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF

SMALL MOLECULE INHIBITORS OF KRAS PROTEINS

INHIBITION OF GLIAL CELL ACTIVATION

PYRROLOPYRIMIDINE ITK INHIBITORS

COMPOUNDS USEFUL IN HIV THERAPY

1H-PYRROLO[3,2-B]PYRIDINE DERIVATIVES AS IRREVERSIBLE INHIBITORS OF MUTANT EGFR FOR THE TREATMENT OF CANCER

COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS

THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION

MODULATORS OF TYK2 PROTEOLYSIS AND ASSOCIATED METHODS OF USE

CO-CRYSTALS OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE AND METHODS

NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTS COMPRISING SUBSTANTIALLY AMORPHOUS MESOPOROUS MAGNESIUM CARBONATE

MULTIFUNCTIONAL CREAM HYDROGELS FOR POSTOPERATIVE ADHESION PREVENTION

COMPOSITIONS COMPRISING LOPINAVIR AND TREATMENT OF CONDITIONS

TREATMENT OF MHC-I NEGATIVE TUMORS WITH NK AND T CELLS

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

All Natural Motion Sickness Solution

2-HYDROXYPROPYL-BETA-CYCLODEXTRIN AS A CANCER THERAPY NEOADJUVANT OR ADJUVANT

TREATMENT OF FRAGILE X SYNDROME AND AUTISM SPECTRUM DISORDER WITH CANNABIDIOL

TOPICAL TREATMENT OF WOUNDS WITH STATINS AND CHOLESTEROL FOR SCAR REDUCTION

METHODS AND COMPOSITIONS FOR TREATING MALIGNANT CANCERS

TREATMENT OF CANCER WITH METASTASES IN THE CENTRAL NERVOUS SYSTEM

USE OF PHARMACEUTICAL COMPOUND IN THE TREATMENT OF SOLID TUMORS

METHODS OF TREATING DISORDERS USING CSF1R INHIBITORS

SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF TREATING SICKLE CELL DISEASE AND RELATED COMPLICATIONS

Macrocyclic ligands for FK506-binding proteins for treatment of diseases with improved characteristics

HODGKIN LYMPHOMA THERAPY

CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS

COMPOSITIONS CONTAINING VERTEPORFIN, RIBAVIRIN, GEMCITABINE, OR COMBINATIONS THEREOF AND METHODS OF USE FOR TREATING COVID-19, CANCER, OR NON CANCER DISEASES

MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF

Compositions and Methods for Treating Metabolic Disorders

CANNABINOID PRODRUG COMPOUNDS

Treatment Method and Product for Uterine Fibroids using Purified Collagenase

EXTENDED RELEASE PHARMACEUTICAL FORMULATION

PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR DISEASES OR DISORDERS

SYSTEMS, COMPOSITIONS, AND METHODS RELATED TO INJECTABLE HYDROGELS

Pharmaceutical Composition and Method of Isotope-Selective Modulation

COMPOSITIONS AND METHODS FOR MICROGLIA REPLACEMENT THERAPY

POLYMER MEDICAMENT FOR TREATING HYPERKALEMIA AND PREPARATION METHOD THEREOF

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

HUMAN MONOCLONAL ANTIBODIES TO FUCOSYL-GM1 AND METHODS FOR USING ANTI-FUCOSYL-GM1 ANTIBODIES

TREATMENT OF GRAFT VERSUS HOST DISEASES USING ANTI-CD122 ANTIBODY

MODIFIED ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF

METHODS OF TREATING NEURODEGENERATIVE DISEASES

PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM

N-(3-(BENZO[B]THIOPHENE-2-CARBOXAMIDO)-PHENYL)-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS LACTATE/ATP PRODUCTION INHIBITORS FOR THE TREATMENT OF CANCER

COMPOUND BASED ON ISOINDOLINE-SUBSTITUTED GLUTARIMIDE BACKBONE AND USE THEREOF

LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS

Biphenyl and Phenylpyridine Compounds

METHODS FOR MAKING AND USING ENDOXIFEN

TECHNIQUES FOR MAGNETIC NANOCLUSTER-BASED COMBINATION THERAPY

SYSTEMS AND METHODS FOR DENTAL TREATMENT WITH EKF

USE OF AKR1C3 INHIBITOR IN PREPARATION OF DRUG FOR TREATING OR PREVENTING METABOLIC ASSOCIATED FATTY LIVER DISEASE

DRUG DELIVERY SYSTEM, TREATMENT KIT, AND METHOD FOR INHIBITING PROLIFERATION OR METASTASIS OF CANCER CELL

Treatment Of Parkinson's Disease With SIM BHLH Transcription Factor 2 (SIM2) Agonists

METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS

MUCISPIRILLUM COMPOSITIONS AND CANCER TREATMENT METHODS THEREOF

COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS

EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING CEBP/BETA

ENTERIC CAPSULE FOR IMPROVING INTESTINAL BACTERIAL FLORA ENCAPSULATING NICOTINAMIDE MONONUCLEOTIDE

MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING

COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA

CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS

SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THE USE THEREOF IN THE TREATMENT AND PREVENTION OF FIBROSIS

LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF

MALLEABLE CONTROLLED RELEASE LOCAL ANESTHETIC WITH HEMOSTATIC COMPOSITION

METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION

PHD INHIBITORS

METHOD OF PREVENTING OR TREATING HEART FAILURE IN A PATIENT USING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE

CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF

Cyclopropane Fatty Acid Modulators Of Peroxisome Proliferator-Activated Receptors

COMPOSITIONS AND METHODS FOR TREATING REPERFUSION INJURY OR HEMORRHAGE AFTER RECANALIZATION THERAPY

METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA

HIGH SURFACE-AREA LYOPHILIZED COMPOSITIONS COMPRISING ARSENIC FOR ORAL ADMINISTRATION IN PATIENTS

GEMFIBROZIL FORMULATION

Use Of Serine/Arginine-Rich Splicing Factor 1 (SRSF1) As Therapeutic Target For Aortic Dissection

ANTI-HIV VACCINE ANTIBODIES WITH REDUCED POLYREACTIVITY

Inhibitors of MENIN-MLL Interaction

COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS

N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (1,3-THIAZOLYL)](SUBSTITUTED)CARBOXAMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING THE AMIDE COMPOUNDS AND OF THEIR USE

CELL-PERMEANT COVALENT INHIBITORS OF VIRAL CYSTEINE PROTEASES

1,2,4-Oxadiazole and Thiadiazole Compounds as Immunomodulators

METHODS FOR TREATING GLIOBLASTOMA OR RECURRENT GLIOBLASTOMA UTILIZING A WIRELESS SIGNAL ALONE OR IN COMBINATION WITH ONE OR MORE CANCER DRUGS, AND ASSOCIATED SYSTEMS, APPARATUSES, AND DEVICES

LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE

ANTIBODIES AND METHODS FOR TREATMENT OF LYSSAVIRUS INFECTION

METHOD FOR TREATMENT OF TUMOR BY USING RECOMBINANT ONCOLYTIC VIRUS IN COMBINATION WITH SMALL-MOLECULE ANTICANCER DRUG

METHODS FOR ENHANCING IMMUNE CHECKPOINT BLOCKADE THERAPY BY MODULATING THE MICROBIOME

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASE

MARIBAVIR ISOMERS, COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING

CANNABINOIDS AND USES THEREOF IN TREATMENT OF A DISEASE

STIMULATOR OF INTERFERON GENES AGONISTS

COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS

Cancer Treatment Targeted to Tumor Adaptive Responses to Protein Synthesis Stress

TREATMENT OF HIDRADENITIS SUPPURATIVA USING JAK INHIBITORS

BIFUNCTIONAL COMPOUNDS CONTAINING PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONE DERIVATIVES FOR DEGRADING CYCLIN-DEPENDENT KINASE 2 VIA UBIQUITIN PROTEASOME PATHWAY

METHODS OF USING ANTI-CD79b IMMUNOCONJUGATES TO TREAT FOLLICULAR LYMPHOMA

METHOD OF TREATING ORGAN DISEASES OR DISORDERS WITH ASK1 INHIBITORS

INHALATION DEVICE FOR 7-OH-MITRAGYNINE

USE OF DEXPRAMIPEXOLE FOR THE TREATMENT OF MODERATE TO SEVERE ASTHMA

METHODS FOR TREATING HETEROTOPIC OSSIFICATION

METHODS AND COMPOSITIONS FOR TREATING PARASITIC DISEASES USING NANOBUBBLES AND ANTI-PARASITIC AGENTS

PHARMACEUTICAL FORMULATIONS

ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS

DOUBLE STRANDED RNAi AGENTS, COMPOSITIONS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER BY TARGETING THE BRCA1 PSEUDOGENE (BRCA1P1)

FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

NEDDYLATION-ACTIVATING ENZYME INHIBITORS AS VIRAL SENSITIZERS AND USES THEREOF

ANTI-POLYSIALIC ACID ANTIBODIES AND USES THEREOF

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS

CD47 BINDING AGENTS

SOLUBLE NPY2 RECEPTOR AGONISTS

CPG AMPHIPHILES AND USES THEREOF

ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF

COMPOUND INCLUDING 2,4-DIAMINOPYRIDINE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY

COMPOUNDS AND METHODS FOR INHIBITION OF THE EVOLUTION OF ANTIBIOTIC RESISTANCE

COMPOSITIONS AND METHODS FOR TREATING CANCER

TREATMENT METHODS FOR VIRAL INFECTIONS

COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS

COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS

ABIRATERONE PRODRUGS

PRODRUGS FOR DELIVERY OF TESTOSTERONE TO THE CENTRAL NERVOUS SYSTEM

NOVEL USES OF DUAL NK-1 /NK-3 RECEPTOR ANTAGONISTS FOR TREATING SEX-HORMONE DISEASES

USE OF ESREBOXETINE TO TREAT NERVOUS SYSTEM DISORDERS SUCH AS FIBROMYALGIA

REHYDRATION COMPOSITION AND METHOD OF USE

Uses of JAK Inhibitors in the Management of Inflammation-Associated Depression and Central Nervous System (CNS) Pathologies

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

Method of Normalizing the Neutrophil to Lymphocyte Ratio in Cancer Patients with a Selective Glucocorticoid Receptor Antagonist

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

COMPOSITION FOR TOPICAL DERMATOLOGICAL DELIVERY

SUBSTITUTED 3-(l-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE/2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-l,3-DIONE ANALOGS AS MODULATORS OF CEREBLON PROTEIN

METHODS OF TREATING MIGRAINE

USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER

SMALL MOLECULE BCL-2 FUNCTIONAL CONVERTERS AS CANCER THERAPEUTICS

METHOD OF TREATING PAH WITH COMBINATIONS OF RALINEPAG AND OTHER AGENTS

COMBINATION REMEDY

PETROLATUM-BASED DELIVERY SYSTEMS AND FOR ACTIVE INGREDIENTS

METHOD FOR CONSTRUCTING GRAM-NEGATIVE BACTERIAL OUTER MEMBRANE-DERIVED NANOVESICLES AND USE THEREOF

IONIZABLE LIPID CONTAINING BIODEGRADABLE ESTER BOND AND LIPID NANOPARTICLES COMPRISING SAME

HYDROGEL BASED ON ZINC GLUCONATE AND HYALURONIC ACID ESTERS

METHODS OF DIAGNOSIS AND GUIDING TREATMENT OF VULVOVAGINAL SYMPTOMS AND FEMALE SEXUAL DYSFUNCTION

PREDICTIVE MIRNAS FOR RESPONSE TO CANCER THERAPY

METHODS AND COMPOSITIONS FOR INCREASING PROTEIN EXPRESSION AND/OR TREATING A HAPLOINSUFFICIENCY DISORDER

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

METHODS OF TREATING DISEASE USING ANTI-IL1RAP ANTIBODIES AND ANTIBODY DRUG CONJUGATES

METHODS FOR VACCINATION OF A SUBJECT TREATED WITH AN FCRN ANTAGONIST

METHODS OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISORDERS

CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF

INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE

COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE

COMPOUNDS WITH BIGUANIDYL RADICAL AND USES THEREOF

RADIOPHARMACEUTICAL SMALL MOLECULE INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN FOR TARGETED THERAPY AND DIAGNOSTIC IMAGING OF DESMOPLASTIC TUMORS

METHODS FOR TREATING AND DIAGNOSING BLINDING EYE DISEASES